Anixa Biosciences Inc - Common Stock (ANIX) Institutional Ownership

13F Institutional Holders and Ownership History from Q4 2018 to Q4 2025

Type / Class
Equity / Common Stock
Symbol
ANIX on Nasdaq
Shares outstanding
35,258,614
Price per share
$3.10
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
5,603,966
Total reported value
$17,481,741
% of total 13F portfolios
0%
Share change
+222,704
Value change
+$692,166
Number of holders
69
Price from insider filings
$3.10
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Anixa Biosciences Inc - Common Stock (ANIX) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
KUMAR AMIT 16% +8% $16,667,362 +$1,403,336 6,173,097 +9.2% Amit Kumar 04 Jun 2025
Catelani Michael 7% $10,662,205 2,468,103 Michael Catelani 05 Jan 2026

As of 31 Dec 2025, 69 institutional investors reported holding 5,603,966 shares of Anixa Biosciences Inc - Common Stock (ANIX). This represents 16% of the company’s total 35,258,614 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Anixa Biosciences Inc - Common Stock (ANIX) together control 15% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
VANGUARD GROUP INC 4.1% 1,459,574 +2.6% 0% $4,553,871
Laird Norton Wetherby Trust Company, LLC 1.7% 588,027 -1.5% 0.04% $1,834,644
D.A. DAVIDSON & CO. 1.5% 539,272 -12% 0.01% $1,682,529
UBS Group AG 1.3% 459,073 -3.2% 0% $1,432,308
GEODE CAPITAL MANAGEMENT, LLC 1% 350,915 +2.1% 0% $1,095,116
SUSQUEHANNA INTERNATIONAL GROUP, LLP 0.71% 252,074 +214% 0% $786,471
MISSION WEALTH MANAGEMENT, LP 0.59% 206,900 -42% 0.01% $645,528
BlackRock, Inc. 0.47% 163,983 +1.8% 0% $511,626
STATE STREET CORP 0.45% 159,040 +32% 0% $496,205
683 Capital Management, LLC 0.32% 113,636 0.03% $354,544
ExodusPoint Capital Management, LP 0.27% 93,931 0% $293,065
LPL Financial LLC 0.25% 89,605 +3% 0% $279,568
GSA CAPITAL PARTNERS LLP 0.23% 82,118 +0.27% 0.02% $256,000
Qube Research & Technologies Ltd 0.17% 59,519 0% $185,699
Bank of New York Mellon Corp 0.17% 58,270 0% 0% $181,802
NORTHERN TRUST CORP 0.16% 55,768 -2.1% 0% $173,996
RENAISSANCE TECHNOLOGIES LLC 0.15% 53,873 +26% 0% $168,084
CoreCap Advisors, LLC 0.14% 48,035 +2.7% 0.01% $149,869
MORGAN STANLEY 0.13% 46,860 +302% 0% $146,203
ACADIAN ASSET MANAGEMENT LLC 0.13% 44,301 +113% 0% $136,000
Westside Investment Management, Inc. 0.12% 44,000 +26% 0.02% $137,280
HighTower Advisors, LLC 0.12% 41,150 0% 0% $128,388
MARSHALL WACE, LLP 0.12% 40,558 -35% 0% $126,541
Corient Private Wealth LLC 0.11% 37,400 0% 0% $116,688
Gemmer Asset Management LLC 0.1% 35,000 0% 0.01% $109,200

Institutional Holders of Anixa Biosciences Inc - Common Stock (ANIX) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 5,603,966 $17,481,741 +$692,166 $3.12 69
2025 Q3 5,413,922 $17,872,434 +$304,259 $3.30 65
2025 Q2 5,349,047 $17,648,439 -$787,212 $3.30 65
2025 Q1 5,605,891 $16,030,193 -$524,324 $2.86 57
2024 Q4 5,841,305 $13,552,284 +$544,864 $2.32 57
2024 Q3 5,576,916 $17,555,837 +$106,953 $3.15 56
2024 Q2 5,565,637 $12,300,146 +$344,963 $2.21 52
2024 Q1 5,283,801 $16,487,763 +$2,705,766 $3.12 58
2023 Q4 4,420,722 $17,152,699 +$1,892,994 $3.88 55
2023 Q3 3,928,249 $12,844,861 +$921,910 $3.27 49
2023 Q2 3,647,399 $11,674,122 -$399,198 $3.20 45
2023 Q1 3,664,627 $15,755,697 +$369,660 $4.30 44
2022 Q4 3,636,173 $15,451,565 +$553,415 $4.25 49
2022 Q3 3,474,510 $17,089,377 +$1,187,300 $4.92 41
2022 Q2 3,267,227 $9,991,989 -$78,782 $3.06 42
2022 Q1 3,302,911 $9,050,644 -$407,464 $2.74 37
2021 Q4 3,436,723 $10,208,000 +$525,035 $2.97 39
2021 Q3 3,177,493 $15,156,000 +$1,098,635 $4.77 34
2021 Q2 2,951,398 $11,453,000 -$36,263,645 $3.88 29
2021 Q1 2,512,086 $49,594,000 +$41,200,982 $4.68 27
2020 Q4 1,800,328 $5,527,000 +$13,066 $3.07 20
2020 Q3 1,825,831 $4,439,000 +$532,898 $2.43 19
2020 Q2 1,596,826 $4,888,000 +$720,757 $3.06 18
2020 Q1 1,382,434 $2,197,000 +$44,107 $1.59 15
2019 Q4 1,327,691 $4,354,000 +$51,850 $3.28 14
2019 Q3 1,311,710 $5,247,000 +$341,126 $4.00 14
2019 Q2 1,226,425 $4,448,000 -$180,456 $3.63 13
2019 Q1 1,251,395 $5,657,000 +$702,078 $4.52 14
2018 Q4 1,095,942 $4,318,000 +$4,318,000 $3.94 13